title: Case Report: Spironolactone Withdrawal Associated With a Dramatic Response in a Patient With Metastatic Castrate-Resistant Prostate Cancer.
authors.affiliation: Department of Medicine, Froedtert and Medical College of Wisconsin, Milwaukee, WI. Electronic address: tiflynn@mcw.edu.
authors.forename: Timothy
authors.initials: T
authors.lastname: Flynn
authors.affiliation: Department of Medicine, University of Rochester Medical Center, Rochester, NY.
authors.forename: Elizabeth A
authors.initials: EA
authors.lastname: Guancial
authors.affiliation: Department of Medicine, Froedtert and Medical College of Wisconsin, Milwaukee, WI.
authors.forename: Maria
authors.initials: M
authors.lastname: Kilari
authors.affiliation: Department of Medicine, Froedtert and Medical College of Wisconsin, Milwaukee, WI.
authors.forename: Deepak
authors.initials: D
authors.lastname: Kilari
mesh_terms: D000069501:Abiraterone Acetate / Q000008:administration & dosage* / Q000627:therapeutic use; D001549:Benzamides; D004336:Drug Antagonism; D006801:Humans; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis; D009570:Nitriles; D010669:Phenylthiohydantoin / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D064129:Prostatic Neoplasms, Castration-Resistant / Q000188:drug therapy*; D013148:Spironolactone / Q000009:adverse effects* / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D001549:Benzamides; D009570:Nitriles; D010669:Phenylthiohydantoin; D013148:Spironolactone; C540278:enzalutamide; D000069501:Abiraterone Acetate
keywords: Abiraterone acetate; Androgen receptor agonist; Androgen receptor modulator; Enzalutamide; Spironolactone